{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:43Z","timestamp":1786119403150,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/shk.0b013e3181c4fb08","type":"journal-article","created":{"date-parts":[[2010,4,8]],"date-time":"2010-04-08T02:54:18Z","timestamp":1270695258000},"page":"507-512","source":"Crossref","is-referenced-by-count":23,"title":["THERAPEUTIC INJECTION OF PARP INHIBITOR INO-1001 PRESERVES CARDIAC FUNCTION IN PORCINE MYOCARDIAL ISCHEMIA AND REPERFUSION WITHOUT REDUCING INFARCT SIZE"],"prefix":"10.1097","volume":"33","author":[{"given":"Jan P.","family":"Roesner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Mersmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bergt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Bohnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Barthuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele E. F.","family":"N\u00f6ldge-Schomburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zacharowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210213","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Mechanisms of disease: myocardial reperfusion injury.","volume":"357","author":"Yellon","year":"2007","journal-title":"N Engl J Med"},{"key":"R2-10-20210213","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1073\/pnas.94.2.679","article-title":"Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle.","volume":"94","author":"Thiemermann","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R3-10-20210213","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1073\/pnas.93.5.1753","article-title":"DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite.","volume":"93","author":"Szabo","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"R4-10-20210213","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly(ADP-ribose): novel functions for an old molecule.","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R5-10-20210213","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2353\/ajpath.2008.080019","article-title":"Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.","volume":"173","author":"Pacher","year":"2008","journal-title":"Am J Pathol"},{"key":"R6-10-20210213","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.yexmp.2007.11.005","article-title":"Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation.","volume":"84","author":"McCourtie","year":"2008","journal-title":"Exp Mol Pathol"},{"key":"R7-10-20210213","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.shk.0000110621.42625.10","article-title":"Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction.","volume":"21","author":"Murthy","year":"2004","journal-title":"Shock"},{"key":"R8-10-20210213","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/sj.bjp.0704185","article-title":"Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences.","volume":"133","author":"Liaudet","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R9-10-20210213","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.RES.83.1.85","article-title":"Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia\/reperfusion injury.","volume":"83","author":"Zingarelli","year":"1998","journal-title":"Circ Res"},{"key":"R10-10-20210213","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11010-008-9929-8","article-title":": Prevalent role of Akt and ERK activation in cardioprotective effect of Ca(2+) channel- and beta-adrenergic receptor blockers.","volume":"321","author":"Kovacs","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"R11-10-20210213","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1582-4934.2008.00183.x","article-title":"Inhibition of the activity of poly (ADP-ribose) polymerase reduces heart ischaemia\/reperfusion injury via suppressing JNK-mediated AIF translocation.","volume":"12","author":"Song","year":"2008","journal-title":"J Cell Mol Med"},{"key":"R12-10-20210213","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1152\/japplphysiol.00830.2004","article-title":"Early time course of myocardial electrical impedance during acute coronary artery occlusion in pigs, dogs, and humans.","volume":"99","author":"del Rio","year":"2005","journal-title":"J Appl Physiol"},{"key":"R13-10-20210213","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/cvr\/21.10.737","article-title":"Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction.","volume":"21","author":"Maxwell","year":"1987","journal-title":"Cardiovasc Res"},{"key":"R14-10-20210213","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/01.CCM.0000269035.30231.76","article-title":": The fibrin-derived peptide Bbeta15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury.","volume":"35","author":"Roesner","year":"2007","journal-title":"Crit Care Med"},{"key":"R15-10-20210213","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11239-008-0230-1","article-title":"A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial.","volume":"27","author":"Morrow","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"R16-10-20210213","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0003-4975(01)03329-X","article-title":"Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor.","volume":"73","author":"Faro","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"R17-10-20210213","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(98)00638-4","article-title":"Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig.","volume":"359","author":"Bowes","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"R18-10-20210213","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.expneurol.2009.02.012","article-title":"Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke.","volume":"217","author":"Yuan","year":"2009","journal-title":"Exp Neurol"},{"key":"R19-10-20210213","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.CIR.0000112575.66565.84","article-title":"Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.","volume":"109","author":"Oyama","year":"2004","journal-title":"Circulation"},{"key":"R20-10-20210213","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6793-7-5","article-title":"Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function.","volume":"7","author":"Kim","year":"2007","journal-title":"BMC Physiol"},{"key":"R21-10-20210213","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0002-9149(03)00148-6","article-title":"Meta-analysis of corticosteroid treatment in acute myocardial infarction.","volume":"91","author":"Giugliano","year":"2003","journal-title":"Am J Cardiol"},{"key":"R22-10-20210213","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/01.RES.0000137171.97172.d7","article-title":"Myocardial protection at a crossroads: the need for translation into clinical therapy.","volume":"95","author":"Bolli","year":"2004","journal-title":"Circ Res"},{"key":"R23-10-20210213","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/01.shk.0000209561.61951.2e","article-title":": The PARP-1 inhibitor INO-1001 facilitates hemodynamic stabilization without affecting DNA repair in porcine thoracic aortic cross-clamping-induced ischemia\/reperfusion.","volume":"25","author":"Hauser","year":"2006","journal-title":"Shock"},{"key":"R24-10-20210213","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1072-7515(03)00538-6","article-title":"Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass.","volume":"197","author":"Khan","year":"2003","journal-title":"J Am Coll Surg"},{"key":"R25-10-20210213","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00134-007-0585-3","article-title":"The selective poly(ADP)ribose-polymerase 1 inhibitor INO1001 reduces spinal cord injury during porcine aortic cross-clamping-induced ischemia\/reperfusion injury.","volume":"33","author":"Maier","year":"2007","journal-title":"Intensive Care Med"},{"key":"R26-10-20210213","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.shk.0000048904.46342.22","article-title":": Systemic and hepatosplanchnic hemodynamic and metabolic effects of the PARP inhibitor PJ34 during hyperdynamic porcine endotoxemia.","volume":"19","author":"Ivanyi","year":"2003","journal-title":"Shock"},{"key":"R27-10-20210213","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejcts.2004.10.055","article-title":"Poly(ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation.","volume":"27","author":"Szabo","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"R28-10-20210213","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/cvr\/cvn114","article-title":"Remote ischaemic preconditioning: underlying mechanisms and clinical application.","volume":"79","author":"Hausenloy","year":"2008","journal-title":"Cardiovasc Res"},{"key":"R29-10-20210213","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1124\/jpet.104.069658","article-title":"A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging.","volume":"311","author":"Pacher","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R30-10-20210213","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3181\/0701-RM-16","article-title":"Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite.","volume":"232","author":"Radovits","year":"2007","journal-title":"Exp Biol Med"},{"key":"R31-10-20210213","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1124\/jpet.104.077164","article-title":"Poly(ADP-ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure.","volume":"312","author":"Xiao","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R32-10-20210213","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jvs.2005.11.021","article-title":"Activation of the peroxynitrite-poly(adenosine diphosphate-ribose) polymerase pathway during neointima proliferation: a new target to prevent restenosis after endarterectomy.","volume":"43","author":"Beller","year":"2006","journal-title":"J Vasc Surg"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00024382-201005000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:13:37Z","timestamp":1786040017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00024382-201005000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0b013e3181c4fb08","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}